- Report
- May 2026
- 550 Pages
Global
From €3631EUR$3,995USD£3,131GBP
- Report
- May 2026
- 250 Pages
Global
From €3631EUR$3,995USD£3,131GBP
- Report
- May 2026
- 450 Pages
Global
From €3631EUR$3,995USD£3,131GBP
- Report
- May 2026
- 300 Pages
Global
From €3631EUR$3,995USD£3,131GBP
- Report
- May 2026
- 500 Pages
Global
From €4540EUR$4,995USD£3,915GBP
- Report
- May 2026
- 800 Pages
Global
From €4540EUR$4,995USD£3,915GBP
- Report
- June 2026
- 465 Pages
Global
From €4086EUR$4,495USD£3,523GBP
- Report
- April 2026
- 424 Pages
Global
From €5221EUR$5,945USD£4,350GBP
- Report
- July 2025
- 422 Pages
Global
From €5221EUR$5,945USD£4,350GBP
- Report
- December 2025
- 972 Pages
Global
From €4362EUR$4,799USD£3,762GBP
- Report
- December 2025
- 250 Pages
Global
From €4362EUR$4,799USD£3,762GBP
- Report
- February 2026
- 320 Pages
Global
From €4499EUR$4,950USD£3,880GBP
- Report
- July 2025
- 117 Pages
Global
From €4226EUR$4,650USD£3,645GBP
- Report
- June 2026
- 192 Pages
Global
From €3222EUR$3,545USD£2,779GBP
€3580EUR$3,939USD£3,088GBP
- Report
- April 2026
- 137 Pages
Global
From €3635EUR$3,999USD£3,135GBP
- Report
- July 2025
Global
From €4454EUR$4,900USD£3,841GBP
- Report
- January 2026
- 120 Pages
Global
From €5408EUR$5,950USD£4,664GBP
- Report
- July 2025
- 150 Pages
Global
From €5408EUR$5,950USD£4,664GBP
- Report
- May 2026
- 295 Pages
Global
From €2272EUR$2,500USD£1,960GBP
- Report
- February 2026
- 250 Pages
Global
From €4081EUR$4,490USD£3,519GBP

CRISPR Therapeutics is a rapidly growing field within the genomics market. It is a gene-editing technology that uses a modified version of the CRISPR-Cas9 system to modify or replace genes in a living organism. This technology has the potential to revolutionize the way diseases are treated, as it can be used to target and modify specific genes that are responsible for certain diseases. It can also be used to create new treatments for diseases that have no existing treatments.
CRISPR Therapeutics has been used to develop treatments for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. It has also been used to create new treatments for rare diseases, as well as to develop new therapies for existing diseases.
Companies in the CRISPR Therapeutics market include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, and Caribou Biosciences. These companies are working to develop treatments for a variety of diseases, as well as to create new therapies for existing diseases. Show Less Read more